534
Participants
Start Date
August 15, 2019
Primary Completion Date
December 3, 2020
Study Completion Date
March 2, 2021
Dexpramipexole
dexpramipexole twice daily oral dosing for up to 12 weeks
Placebo
placebo twice daily oral dosing for up to 12 weeks
Research Site, New Hyde Park
Research Site, Corning
Research Site, Pittsburgh
Research Site, Winston-Salem
Research Site, Raleigh
Research Site, North Charleston
Research Site, Anderson
Research Site, Lawrenceville
Research Site, Winder
Research Site, Daytona Beach
Research Site, Orlando
Research Site, Miami
Research Site, Tampa
Research Site, Tampa
Research Site, Dublin
Research Site, Columbus
Research Site, Cincinnati
Research Site, Cincinnati
Research Site, Farmington Hills
Research site, Plymouth
Research Site, St Louis
Research Site, St Louis
Research Site, Edmond
Research Site, Allen
Research Site, Dallas
Research Site, Boerne
Research Site, El Paso
Research Site, Denver
Research Site, Boise
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Westminster
Research Site, Mission Viejo
Research Site, Portland
Research Site, Medford
Research Site, New Brunswick
Lead Sponsor
Knopp Biosciences
INDUSTRY